Table 1.
Baseline characteristics
| Bacteremia + | Bacteremia − | P value | |||
|---|---|---|---|---|---|
| N | % | N | % | ||
| 93 | 12.16 % | 672 | 87.84 % | ||
| Age, yrs | |||||
| Mean [SD] | 58.4 [14.1] | 58.8 [17.8] | |||
| Median (IQR) | 58.5 (53.4, 67.6) | 60.8 (48.1, 72.3) | 0.622 | ||
| Race | |||||
| Caucasian | 51 | 54.84 % | 424 | 63.10 % | 0.392 |
| African-American | 39 | 41.94 % | 213 | 31.70 % | |
| Asian | 0 | 0.00 % | 5 | 0.74 % | |
| Other | 0 | 0.00 % | 6 | 0.89 % | |
| Unknown | 3 | 3.23 % | 24 | 3.57 % | |
| Gender, female | 35 | 37.63 % | 290 | 43.15 % | 0.580 |
| BMI | |||||
| Mean [SD] | 28.6 [9.1] | 29.0 [10.1] | |||
| Median (IQR) | 27.5 (21.9, 33.5) | 26.9 (22.2, 33.3) | 0.941 | ||
| Hospitalization in previous 180 days | 45 | 48.39 % | 253 | 37.65 % | 0.047 |
| Comorbidities | |||||
| MI | 12 | 12.90 % | 74 | 11.01 % | 0.599 |
| CHF | 21 | 22.58 % | 140 | 20.83 % | 0.685 |
| PVD | 13 | 13.98 % | 82 | 12.20 % | 0.616 |
| CVD | 11 | 11.83 % | 74 | 11.01 % | 0.860 |
| Dementia | 3 | 3.23 % | 11 | 1.64 % | 0.237 |
| COPD | 30 | 32.26 % | 210 | 31.25 % | 0.905 |
| Connective tissue disease | 2 | 2.15 % | 22 | 3.27 % | 0.757 |
| PUD | 6 | 6.45 % | 24 | 3.57 % | 0.246 |
| CLD | 16 | 17.20 % | 64 | 9.52 % | 0.030 |
| DM | 25 | 26.88 % | 158 | 23.51 % | 0.517 |
| CKD | 20 | 21.51 % | 99 | 14.73 % | 0.095 |
| CA | 19 | 20.43 % | 142 | 21.13 % | 1.000 |
| HIV | 1 | 1.08 % | 4 | 0.60 % | 0.478 |
| Charlson score | |||||
| Mean [SD] | 4.4 [3.3] | 4.2 [3.4] | |||
| Median (IQR) | 4 (2, 6) | 3 (1, 6) | 0.340 |
SD standard deviation, IQR interquartile range, BMI body mass index, MI myocardial infarction, CHF congestive heart failure, PVD peripheral vascular disease, CVD cerebrovascular disease, COPD chronic obstructive pulmonary disease, PUD peptic ulcer disease, CLD chronic liver disease, DM diabetes mellitus, CKD chronic kidney disease, CA cancer, HIV human immunodeficiency virus